Concepedia

Przemyslaw Chimiczewski

PC

Statistics

Publications

1

Citations

53

H-Index

1

Active since

2019

Affiliations

Augusta University Health(Current)

Przemyslaw Chimiczewski is an author at Augusta University Health specializing in gynecologic oncology, phase ii investigation, and chemotherapy.

Publications per year

2019–2019

1

Publications

1

EMR 20006-012: A phase II randomized double-blind placebo controlled trial comparing the combination of pimasertib (MEK inhibitor) with SAR245409 (PI3K inhibitor) to pimasertib alone in patients with previously treated unresectable borderline or low grade ovarian cancer

Rebecca C. Arend, Allison M. Davis, Przemyslaw Chimiczewski et al. · Gynecologic Oncology · 2019 · 53 citations

, , +17

1–1 of 1